Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-04-06 Sale |
2023-04-10 4:05 pm |
Omega Therapeutics Inc. | OMGA | Young Richard A Director |
5,000 | $8 | $40,000 | 749,118 (Direct) |
View |
| 2023-03-17 Sale |
2023-03-20 4:05 pm |
Omega Therapeutics Inc. | OMGA | Young Richard A Director |
10,000 | $8 | $80,000 | 754,118 (Direct) |
View |
| 2023-02-27 Purchase |
2023-02-27 5:20 pm |
Omega Therapeutics Inc. | OMGA | Flagship Pioneering Inc. Flagship Pioneering Special Opportunities Fund II General Partner LLC Flagship Pioneering Special Opportunities Fund II L.P. AFEYAN NOUBAR 10% Owner |
3,323,310 | $5.78 | $19,208,732 | 21,716,886 (Indirect) |
View |
| 2023-01-10 Sale |
2023-01-11 4:14 pm |
Omega Therapeutics Inc. | OMGA | Young Richard A Director |
20,000 | $8 | $160,000 | 764,118 (Direct) |
View |
| 2022-09-14 Sale |
2022-09-15 4:10 pm |
Omega Therapeutics Inc. | OMGA | Young Richard A Director |
10,000 | $8 | $80,000 | 784,118 (Direct) |
View |
| 2021-08-03 Purchase |
2021-08-05 5:43 pm |
Omega Therapeutics Inc. | OMGA | Flagship Pioneering Inc. Flagship Ventures Fund V General Partner LLC Flagship V VentureLabs Rx Fund L.P. Flagship Ventures Fund V L.P. Flagship VentureLabs V Manager LLC Flagship VentureLabs V LLC 10% Owner |
1,176,469 | $17 | $19,999,973 | 3,814,705 (Indirect) |
View |
| 2021-08-03 Purchase |
2021-08-05 5:41 pm |
Omega Therapeutics Inc. | OMGA | Flagship Pioneering Inc. Flagship Pioneering Fund VI General Partner LLC Flagship Pioneering Fund VI L.P. Flagship Pioneering Special Opportunities Fund II L.P. Flagship Pioneering Special Opportunities Fund II General Partner LLC Nutritional Health LTP Fund L.P. Nutritional Health LTP Fund General Partner LLC FPN General Partner LLC FPN L.P. AFEYAN NOUBAR 10% Owner |
1,176,469 | $17 | $19,999,973 | 3,814,705 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-28 Option Award |
2023-03-02 4:05 pm |
N/A 2033-02-27 |
Omega Therapeutics Inc. | OMGA | Moore Yan Chief Medical Officer |
55,000 | $0 | 55,000 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-02 4:05 pm |
N/A 2033-02-27 |
Omega Therapeutics Inc. | OMGA | McManus Kevin Chief Human Resources Officer |
55,000 | $0 | 55,000 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-02 4:05 pm |
N/A 2033-02-27 |
Omega Therapeutics Inc. | OMGA | Karande Mahesh President and CEO |
170,000 | $0 | 170,000 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-02 4:05 pm |
N/A 2033-02-27 |
Omega Therapeutics Inc. | OMGA | Zeng Ling See Remarks |
55,000 | $0 | 55,000 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-02 4:05 pm |
N/A 2033-02-27 |
Omega Therapeutics Inc. | OMGA | Reed Joshua Chief Financial Officer |
55,000 | $0 | 55,000 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-02 4:05 pm |
N/A 2033-02-27 |
Omega Therapeutics Inc. | OMGA | McCauley Thomas Chief Scientific Officer |
55,000 | $0 | 55,000 (Direct) |
View |
Ownership |
2023-02-27 5:20 pm |
N/A N/A |
Omega Therapeutics Inc. | OMGA | Flagship Pioneering Fund VII General Partner LLC Flagship Pioneering Fund VII L.P. 10% Owner |
0 | $0 | 1,329,324 (Indirect) |
View |
| 2022-10-27 Option Award |
2022-10-28 6:43 pm |
N/A 2032-10-26 |
Omega Therapeutics Inc. | OMGA | Karande Mahesh President and CEO |
170,000 | $0 | 170,000 (Direct) |
View |
| 2022-10-27 Option Award |
2022-10-28 6:40 pm |
N/A 2032-10-26 |
Omega Therapeutics Inc. | OMGA | McCauley Thomas Chief Scientific Officer |
55,000 | $0 | 55,000 (Direct) |
View |
| 2022-10-27 Option Award |
2022-10-28 6:39 pm |
N/A 2032-10-26 |
Omega Therapeutics Inc. | OMGA | Zeng Ling See Remarks |
55,000 | $0 | 55,000 (Direct) |
View |
| 2022-10-27 Option Award |
2022-10-28 6:39 pm |
N/A 2032-10-26 |
Omega Therapeutics Inc. | OMGA | McManus Kevin Chief Human Resources Officer |
55,000 | $0 | 55,000 (Direct) |
View |
| 2022-10-27 Option Award |
2022-10-28 6:38 pm |
N/A 2032-10-26 |
Omega Therapeutics Inc. | OMGA | Moore Yan Chief Medical Officer |
55,000 | $0 | 55,000 (Direct) |
View |
| 2022-10-27 Option Award |
2022-10-28 6:36 pm |
N/A 2032-10-26 |
Omega Therapeutics Inc. | OMGA | Reed Joshua Chief Financial Officer |
55,000 | $0 | 55,000 (Direct) |
View |
| 2022-08-31 Option Award |
2022-09-01 4:27 pm |
N/A 2032-08-30 |
Omega Therapeutics Inc. | OMGA | Boehm Rainer J. Director |
36,713 | $0 | 36,713 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:10 pm |
N/A 2032-06-07 |
Omega Therapeutics Inc. | OMGA | Levy Elliott M. Director |
18,118 | $0 | 18,118 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:10 pm |
N/A 2032-06-07 |
Omega Therapeutics Inc. | OMGA | MENDLEIN JOHN Director |
18,118 | $0 | 18,118 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:10 pm |
N/A 2032-06-07 |
Omega Therapeutics Inc. | OMGA | BESHAR LUKE M Director |
18,118 | $0 | 18,118 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:10 pm |
N/A 2032-06-07 |
Omega Therapeutics Inc. | OMGA | AFEYAN NOUBAR Director 10% Owner |
18,118 | $0 | 18,118 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:10 pm |
N/A 2032-06-07 |
Omega Therapeutics Inc. | OMGA | Young Richard A Director |
18,118 | $0 | 18,118 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:10 pm |
N/A 2032-06-07 |
Omega Therapeutics Inc. | OMGA | Szela Mary T Director |
18,118 | $0 | 18,118 (Direct) |
View |
| 2022-05-31 Option Award |
2022-06-02 6:51 pm |
N/A 2032-05-30 |
Omega Therapeutics Inc. | OMGA | Reed Joshua Chief Financial Officer |
320,000 | $0 | 320,000 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-01 4:20 pm |
N/A 2032-03-30 |
Omega Therapeutics Inc. | OMGA | McManus Kevin Chief Human Resources Officer |
125,000 | $0 | 125,000 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-01 4:20 pm |
N/A 2032-03-30 |
Omega Therapeutics Inc. | OMGA | Zeng Ling See Remarks |
270,000 | $0 | 270,000 (Direct) |
View |
| 2022-03-09 Option Award |
2022-03-11 4:05 pm |
N/A 2032-03-08 |
Omega Therapeutics Inc. | OMGA | Karande Mahesh President and CEO |
340,000 | $0 | 340,000 (Direct) |
View |
| 2022-03-09 Option Award |
2022-03-11 4:05 pm |
N/A 2032-03-08 |
Omega Therapeutics Inc. | OMGA | McCauley Thomas Chief Scientific Officer |
110,000 | $0 | 110,000 (Direct) |
View |
| 2022-03-09 Option Award |
2022-03-11 4:05 pm |
N/A 2032-03-08 |
Omega Therapeutics Inc. | OMGA | Sawhney Roger Chief Financial Officer |
60,000 | $0 | 60,000 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-03 4:05 pm |
N/A 2029-06-23 |
Omega Therapeutics Inc. | OMGA | Karande Mahesh President and CEO |
11,300 | $0 | 1,001,782 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-03 4:05 pm |
N/A N/A |
Omega Therapeutics Inc. | OMGA | Karande Mahesh President and CEO |
11,300 | $0.53 | 1,001,782 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 4:05 pm |
N/A 2032-01-30 |
Omega Therapeutics Inc. | OMGA | Moore Yan Chief Medical Officer |
477,715 | $0 | 477,715 (Direct) |
View |
| 2021-08-03 Conversion |
2021-08-05 5:43 pm |
N/A N/A |
Omega Therapeutics Inc. | OMGA | Flagship Pioneering Inc. Flagship Ventures Fund V General Partner LLC Flagship V VentureLabs Rx Fund L.P. Flagship Ventures Fund V L.P. Flagship VentureLabs V Manager LLC Flagship VentureLabs V LLC 10% Owner |
107,637,306 | $0 | 3,814,705 (Indirect) |
View |
| 2021-08-03 Conversion |
2021-08-05 5:41 pm |
N/A N/A |
Omega Therapeutics Inc. | OMGA | Flagship Pioneering Inc. Flagship Pioneering Fund VI General Partner LLC Flagship Pioneering Fund VI L.P. Flagship Pioneering Special Opportunities Fund II L.P. Flagship Pioneering Special Opportunities Fund II General Partner LLC Nutritional Health LTP Fund L.P. Nutritional Health LTP Fund General Partner LLC FPN General Partner LLC FPN L.P. AFEYAN NOUBAR 10% Owner |
107,637,306 | $0 | 3,814,705 (Indirect) |
View |